(Q40918141)

24 September 2017

title

Effect of probucol in hyperlipidemic patients during two years of administration (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

26 June 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

26 June 2022

author name string

Parsons WB Jr

1

1 reference

24 September 2017

W. B. Parsons

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354360

26 June 2022

language of work or name

English

0 references

publication date

1 August 1978

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:0002870378900881?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

https://api.elsevier.com/content/article/PII:0002870378900881?httpAccept=text/plain

26 June 2022

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

26 June 2022

published in

American Heart Journal

1 reference

24 September 2017

volume

96

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

213-217

1 reference

Hypocholestece:rolesmic Effect of 4,4′-(Isopropylidenedithio)-Bis(2,6-di-t-Butylphenol) (Probucol)

24 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Toxicity of (4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol)), probucol, in mice, rats, dogs and monkeys: demonstration of a species-specific phenomenon.

5 April 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Sensitization to epinephrine-induced ventricular fibrillation produced by probucol in dogs

5 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Newer hypolipidemic agents

5 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol

5 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Biphenabid (Probucol): a new hypocholesterolemic agent

5 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Endocrine and metabolic indices during administration of a lipophilic bis‐phenol, probucol

5 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia.

5 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Long-Term Oral Administration of Probucol [4, 4‘-(Isopropylidenedithio) bis (2, 6-di-t-Butylphenol)] (DH-581) in the Management of Hypercholesterolemia*

5 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

The additive effect of probucol on diet in hyperlipidemia

5 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Probucol: A new cholesterol-lowering drug effective in patients with type II hyperlipoproteinemia

5 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia

5 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

A SEMIAUTOMATED PROCEDURE FOR THE DETERMINATION OF TRIGLYCERIDES IN SERUM

5 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer

5 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

5 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders

5 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

5 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

5 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

5 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90088-1

5 April 2023

Identifiers

1 reference

24 September 2017

1 reference